Security key
403783103
GYRE THERAPEUTICS, INC. - Common Stock, par value $0.001 per share (GYRE)
CUSIP: 403783103
Q3 2026 13F Holders as of 30 Sep 2026
- Security type / class
- Equity / Common Stock, par value $0.001 per share
- Total 13F shares
- 945
- Total 13F value
- $6,927
- Share change
- -5,094
- SEC-reported price per share
- $7.33
- Number of holders
- 4
- Value change
- -$32,916
- Number of buys
- 2
- Number of sells
- 4
- Shares outstanding
- 124,924,768
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q3 2026
Institutions
4
Top holders
5
GYRE full security history
Ownership snapshot
Full 13F holder table
Previous quarter: Q2 2026
GYRE THERAPEUTICS, INC. SEC filings
GYRE THERAPEUTICS, INC. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 403783103
Recent filing periods:
Ownership snapshot
Top reported holders of GYRE - GYRE THERAPEUTICS, INC. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
GNI Group Ltd.
Disclosed value leader
GNI Group Ltd.
Comparable rows
3/15
Latest evidence
30 Jun 2026
13D/G
3/4/5
13F
Lead comparable stake: 69%
12 rows are not safely comparable across share classes.
13D/G row: GNI Group Ltd.
Showing 1-6 of 15 holder rows.
Quick read
GNI Group Ltd. leads the comparable SEC ownership view at 69%.
3 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens GNI Group Ltd.'s linked filing trail.
Comparable ownership
Top 3
GNI Group Ltd.
69%
Ying Luo
8.6%
Songjiang Ma
6.3%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| GNI Group Ltd. |
13D/G
3/4/5
10%+ Owner
|
69%
Reported 13D/G
· 04 May 2026
|
$637,927,081
86,323,015 shares
|
$0 | 04 May 2026 |
| Ying Luo |
13D/G
3/4/5
Chief Executive Officer, Director
|
8.6%
Reported 13D/G
· 04 May 2026
|
$75,462,150
10,211,387 shares
|
$0 | 04 May 2026 |
| Songjiang Ma |
13D/G
3/4/5
President, Director
|
6.3%
Reported 13D/G
· 04 May 2026
|
$54,258,348
7,342,131 shares
|
$0 | 04 May 2026 |
| GNI USA, Inc. |
3/4/5
10%+ Owner
|
—
denominator unverified
|
—
2,143,706 shares
|
— | 04 May 2026 |
| HSG Holding Ltd |
13F
Company
|
—
denominator unverified
|
$24,714,470
3,750,299 shares
|
— | 30 Jun 2026 |
| BlackRock, Inc. |
13F
Company
|
—
denominator unverified
|
$6,550,085
993,943 shares
|
— | 30 Jun 2026 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2026
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
4
Shares
945
Rows available
4
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2026 vs Q2 2026 Across Filers
Q2 2026 holders
58
Q3 2026 holders
4
Holder diff
-54
| Investor | Q2 2026 Shares | Q3 2026 Shares | Share Diff | Share Chg % | Q2 2026 value | Q3 2026 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend